ArticleTherapeutic advances in medical oncology2026

Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer.

Dongli Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.